Literature DB >> 30140971

A Modified Low-Cost Technique of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Two Patients: a Solution for Pseudomyxoma Peritonei in the Indian Scenario?

Anil Kumar Singh Rana1, Nitin Agarwal2, Sushant Dutta1, Manoj Kumar Dokania1, Himank Goyal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30140971     DOI： 10.1007/s12029-018-0161-9

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  14 in total

Review 1.  The natural history, gross pathology, and histopathology of appendiceal epithelial neoplasms.

Authors:  P H Sugarbaker
Journal:  Eur J Surg Oncol       Date:  2006-04-18       Impact factor: 4.424

Review 2.  Pseudomyxoma peritonei.

Authors:  Robert M Smeenk; Sjoerd C Bruin; Marie-Louise F van Velthuysen; Victor J Verwaal
Journal:  Curr Probl Surg       Date:  2008-08       Impact factor: 1.909

3.  Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.

Authors:  Adrian Cravioto-Villanueva; Magdalena Cavazos; Pedro Luna-Perez; Hector Martinez-Gomez; María Lourdes Ramirez; Juan Solorzano; Hermelindo Montiel; Jesus Esquivel
Journal:  Surg Today       Date:  2016-04-30       Impact factor: 2.549

4.  Cytoreduction with hyperthermic intraperitoneal chemotherapy: an appraisal of outcomes and cost at a newly established peritoneal malignancy program.

Authors:  Nathan M Hinkle; James MacDonald; John P Sharpe; Paxton Dickson; Jeremiah Deneve; Gitonga Munene
Journal:  Am J Surg       Date:  2016-03-21       Impact factor: 2.565

5.  Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy.

Authors:  D Elias; F Gilly; F Quenet; J M Bereder; L Sidéris; B Mansvelt; G Lorimier; O Glehen
Journal:  Eur J Surg Oncol       Date:  2010-03-12       Impact factor: 4.424

6.  A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C.

Authors:  Konstantinos Votanopoulos; Chukwuemeka Ihemelandu; Perry Shen; John Stewart; Gregory Russell; Edward A Levine
Journal:  J Surg Res       Date:  2012-03-10       Impact factor: 2.192

7.  Using a heating cable within the abdomen to make hyperthermic intraperitoneal chemotherapy easier: feasibility and safety study in a pig model.

Authors:  P Ortega-Deballon; O Facy; G Magnin; F Piard; B Chauffert; P Rat
Journal:  Eur J Surg Oncol       Date:  2009-12-02       Impact factor: 4.424

8.  Initial experience with hyperthermic intra peritoneal chemotherapy and cytoreductivesurgery.

Authors:  N Dharmadhikari; R Shah; P Jagannath
Journal:  Indian J Cancer       Date:  2014 Apr-Jun       Impact factor: 1.224

9.  Preliminary Experience and Morbidity Analysis of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) from a Tertiary Cancer Center in India.

Authors:  Naveen Padmanabhan; Barath Raj Kumar; Ansar Pullampara Pookunju; Ayyapan Srinivasan; Vikash Mahajan
Journal:  J Clin Diagn Res       Date:  2015-06-01

10.  Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C.

Authors:  Laura A Lambert; Terri S Armstrong; J Jack Lee; Suyu Liu; Matthew H G Katz; Cathy Eng; Robert A Wolff; Melissa L Tortorice; Pier Tansey; Santiago Gonzalez-Moreno; Donald H Lambert; Paul F Mansfield
Journal:  Ann Surg Oncol       Date:  2009-05-28       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.